CAFs-derived HGF inhibits paclitaxel-induced apoptosis of lung cancer cells by increasing the expression of the PI3K/Akt pathway and glucose-regulated protein 78 (GRP78), which supports cancer cell survival and contributes to chemoresistance [485,486,487,488,489,490,491,492]. The gene discussed is AKT1; the disease is lung carcinoma.